Impact of exacerbations on lung function, resource utilization, and productivity: results from an observational, prospective study in adults with uncontrolled asthma

被引:5
|
作者
Wisnivesky, Juan [1 ,2 ]
Federmann, Emily [1 ]
Eckert, Laurent [3 ]
West, Erin [4 ]
Amand, Caroline [3 ]
Kamar, Driss [5 ]
Teper, Ariel [6 ]
Khan, Asif H. [3 ]
机构
[1] Icahn Sch Med Mt Sinai, Div Gen Internal Med, Box 1087,One Gustave L Levy Pl, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Pulm & Crit Care Med, New York, NY 10029 USA
[3] Sanofi, Chilly Mazarin, France
[4] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
[5] Ividata Life Sci, Levallois Perret, France
[6] Sanofi, Bridgewater Township, NJ USA
关键词
Forced expiratory volume; symptom exacerbation; airway disease; asthma exacerbations; healthcare resource utilization; DECLINE;
D O I
10.1080/02770903.2022.2130800
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Exacerbations have a major impact on the well-being of patients with uncontrolled asthma. This study evaluated lung function, healthcare resource utilization (HCRU), and productivity loss following asthma exacerbations.Methods: This single-center, observational, prospective cohort study recruited US patients presenting clinically with an acute asthma exacerbation; a reference group without exacerbations was included for comparison. Lung function (forced expiratory volume in 1 second [FEV1]) was collected at baseline, daily during Month 1, and monthly for Months 2-5, and reported as FEV1 percent predicted (FEV(1)pp). HCRU (outpatient visits to a healthcare practitioner, emergency room [ER] visits, and hospitalizations for asthma), oral corticosteroid (OCS) use, and asthma-related work/school absence were collected monthly for 6 months.Results: Overall, 150 patients were recruited (exacerbation: n=102; reference: n=48; mean [SD] age: 42.7 [15.2] and 49.6 [12.4] years; female: 73% and 71%). In both groups, similar trends were observed in FEV1, with significant improvement from baseline to Week 1 (p<0.05), followed by a continuous decline. FEV(1)p was 7.7% lower at baseline and 8.6% lower at Month 5 in the exacerbation group versus the reference group. The exacerbation group had significantly higher rates of OCS prescription during follow-up versus reference group (p=0.04). Over half (52.9%) of patients in the exacerbation group had a recurrent exacerbation during follow-up, increased HCRU (outpatient visits, ER visits, and hospitalizations), and impaired productivity.Conclusion: Although patients with exacerbations had rapid recovery of lung function, this was not maintained and declined faster than in patients without exacerbations. Additionally, patients experienced increased HCRU after exacerbations.
引用
收藏
页码:1072 / 1079
页数:8
相关论文
共 50 条
  • [31] Quantitative CT Imaging in Adults with Asthma Can Predict Both Future Lung Function Decline and Asthma Morbidity: Results from the SARP III Study
    Krings, J. G.
    Goss, C.
    Lew, D.
    Samant, M.
    McGregor, M.
    Boomer, J. S.
    Bacharier, L. B.
    Sheshadri, A.
    Hall, C.
    Brownell, J.
    Schechtman, K.
    Peterson, S.
    McEleney, S.
    Mauger, D.
    Fahy, J. V.
    Fain, S. B.
    Denlinger, L. C.
    Washko, G. R.
    Hoffman, E. A.
    Wenzel, S. E.
    Castro, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [32] Dupilumab Reduced Severe Exacerbations and Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Eosinophilic Phenotype Across Baseline IgE Levels: LIBERTY ASTHMA QUEST Study
    Carr, W. W.
    Corren, J.
    Casale, T. B.
    Daizadeh, N.
    Khan, A. H.
    Kamat, S.
    Deniz, Y.
    Rowe, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [33] Dupilumab reduces exacerbations and improves lung function in uncontrolled, moderate-to-severe asthma patients across prior historical exacerbation subgroups in the phase 3 LIBERTY ASTHMA QUEST study
    Ford, L.
    Corren, J.
    Kuna, P.
    Dong, Q.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Amin, N.
    Pirozzi, G.
    Ruddy, M.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    ALLERGY, 2018, 73 : 464 - 465
  • [34] Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: Results from SARP-3
    Krings, James G.
    Goss, Charles W.
    Lew, Daphne
    Samant, Maanasi
    McGregor, Mary Clare
    Boomer, Jonathan
    Bacharier, Leonard B.
    Sheshadri, Ajay
    Hall, Chase
    Brownell, Joshua
    Schechtman, Ken B.
    Peterson, Samuel
    McEleney, Stephen
    Mauger, David T.
    V. Fahy, John
    Fain, Sean B.
    Denlinger, Loren C.
    Israel, Elliot
    Washko, George
    Hoffman, Eric
    Wenzel, Sally E.
    Castro, Mario
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (03) : 752 - 762
  • [35] Impact of intubated vs. non-intubated anesthesia on postoperative diaphragmatic function: Results from a prospective observational study
    Steinberg, Irene
    Bisciaio, Agnese
    Rosboch, Giulio Luca
    Ceraolo, Edoardo
    Guerrera, Francesco
    Ruffini, Enrico
    Brazzi, Luca
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [36] Tezepelumab Reduces Exacerbations Across All Seasons In Patients With Severe, Uncontrolled Asthma With Seasonal Allergy: Results From The Phase 3 NAVIGATOR Study
    Corren, Jonathan
    Lindsley, Andrew
    Spahn, Joseph
    Cook, Bill
    Griffiths, Janet
    Martin, Nicole
    Colice, Gene
    Pavord, Ian
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB194 - AB194
  • [37] Seasonal Variability of Exacerbations in Patients with Severe, Uncontrolled Asthma and Clinical Benefits of Tezepelumab: Results from the PATHWAY Phase 2b Study
    Corren, J.
    Karpefors, M.
    Hellqvist, A.
    Parnes, J. R.
    Colice, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [38] Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study
    Corren, J.
    Karpefors, M.
    Hellqvist, A.
    Parnes, J. R.
    ALLERGY, 2020, 75 : 17 - 18
  • [39] The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS)
    Miravitlles, Marc
    Worth, Heinrich
    Soler-Cataluna, Juan Jose
    Price, David
    De Benedetto, Fernando
    Roche, Nicolas
    Godtfredsen, Nina S.
    van der Molenh, Thys
    Lofdahl, Claes-Goran
    Padulles, Laura
    Ribera, Anna
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (05) : 561 - 568
  • [40] Impact of clinical factors on calorie and protein intakes during Icu stay in adults trauma patients: results from a prospective observational study
    Davari, Mina
    Moludi, Jalal
    Jafarabadi, Mohammad Asghari
    Ahmadi-Nejad, Mehdi
    Sanaie, Sarvin
    Aref-Hosseini, Seyed-Rafi
    INTERNATIONAL JOURNAL OF BURNS AND TRAUMA, 2019, 9 (03): : 59 - 65